Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
BA.5.2.11NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
BA.2.53NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
BA.4.3NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
EU.1.1.2NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
CM.2.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
XBB.1.43NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
HU.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
JB.2NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.1.144NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.1.288NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.249NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.1.378NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.97NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.9NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.439NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.1.408NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.1.256NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
Q.7 (Alpha)NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.460NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.1.262NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
EG.9NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
XBUNSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.351.5 (Beta)NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
FZ.1.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
XBB.1.9.7NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
XBC.1.6.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
FL.4.4NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
FQ.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
JB.1.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
XBB.1.17NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
FL.3.4NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
FZ.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
DV.7.2NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
FL.6NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
FL.30.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
XBB.1.5.68NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
CD.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
AY.122.3 (Delta)NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
XBB.1.5.55NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
HH.8.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
FL.19NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
FM.2NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
FK.1.2NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
XBB.2.7.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
XBB.8.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
EU.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
XBB.1.14NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
XBB.1.21NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
EJ.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
BM.1.1.5NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used